David P. Schenkein

2018

In 2018, David P. Schenkein earned a total compensation of $8.2M as President and Chief Executive Officer at Agios Pharmaceuticals, a 37% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$507,813
Option Awards$5,160,125
Salary$625,000
Stock Awards$1,893,938
Other$12,448
Total$8,199,324

Schenkein received $5.2M in option awards, accounting for 63% of the total pay in 2018.

Schenkein also received $507.8K in non-equity incentive plan, $625K in salary, $1.9M in stock awards and $12.4K in other compensation.

Rankings

In 2018, David P. Schenkein's compensation ranked 986th out of 14,244 executives tracked by ExecPay. In other words, Schenkein earned more than 93.1% of executives.

ClassificationRankingPercentile
All
986
out of 14,244
93rd
Division
Manufacturing
326
out of 5,765
94th
Major group
Chemicals And Allied Products
99
out of 2,128
95th
Industry group
Drugs
77
out of 1,817
96th
Industry
Pharmaceutical Preparations
52
out of 1,391
96th

Pay ratio

David P. Schenkein's Pay$8,199,324
Median Employee's Pay$345,181
Pay Ratio

24

to 1

In 2018, the annual total compensation of David P. Schenkein was $8,199,324.

The annual total compensation of the median employee at Agios Pharmaceuticals was $345,181.

The ratio of David P. Schenkein's pay to the pay of median employee was therefore 24 to one.

Source: SEC filing on April 18, 2019.

Schenkein's colleagues

We found four more compensation records of executives who worked with David P. Schenkein at Agios Pharmaceuticals in 2018.

2018

Andrew Hirsch

Agios Pharmaceuticals

Chief Financial Officer

2018

Christopher Bowden

Agios Pharmaceuticals

Chief Medical Officer

2018

Scott Biller

Agios Pharmaceuticals

Chief Scientific Officer

2018

Steve Hoerter

Agios Pharmaceuticals

Chief Commercial Officer

News

In-depth

You may also like